Publications by authors named "Helen Howard"

Claim this Profile
S
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, Lisa Pickering, Tom Waddell, Helen Howard

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.
Jon Wadsley, Gemma Ainsworth, Amy Beth Coulson, Kate Garcez, Laura Moss, Helen Howard

Thyroid· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer.
Anjali Zarkar, Dan Henderson, Antony Carver, Geoff Heyes, Victoria Harrop, Helen Howard

BJUI Compass· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.
Oliver Coen, Pippa Corrie, Helen Marshall, Ruth Plummer, Christian Ottensmeier, Helen Howard

BMC Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial.
Peter S Hall, Daniel Swinson, David A Cairns, Justin S Waters, Russell Petty, Helen Howard

JAMA Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Helen H Howard

JAMA Neurol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC).
Zoe Craig, Jayne Swain, Emma Batman, Jonathan Wadsley, Nicholas Reed, Helen Howard

BMJ Open· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.
Hannah L Buckley, Fiona J Collinson, Gemma Ainsworth, Heather Poad, Louise Flanagan, Helen C Howard

BMC Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Helen H Howard

Pharmacol Res Perspect· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palaeoproteomic Profiling of Conservation Layers on a 14th Century Italian Wall Painting.
Meaghan Mackie, Patrick Rüther, Diana Samodova, Fabiana Di Gianvincenzo, Clara Granzotto, Helen Howard

Angew Chem Int Ed Engl· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.
Helena M Earl, Louise Hiller, Helen C Howard, Janet A Dunn, Jennie Young

Lancet Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fight for funding.
Helen Howard

Midwives· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancer.
Fiona J Collinson, Walter M Gregory, Chris McCabe, Helen Howard, Catherine Lowe

BMC Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer.
Fiona J Collinson, David G Jayne, Alessio Pigazzi, Charles Tsang, Jennifer M Barrie, Helen Howard

Int J Colorectal Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Images in vascular medicine. Aortic dissection or extra-aortic artefact?
Vivek Shrivastava, Helen Howard, Peter Gaines

Vasc Med· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agonist-specific, high-affinity binding epitopes are contributed by an arginine in the N-terminus of the human oxytocin receptor.
Victoria J Wesley, Stuart R Hawtin, Helen C Howard, Mark Wheatley

Biochemistry· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis